Currently an exhibitor? Visit our Exhibitor Resource Center for up-to-date information.

Pri-Med South 2013

Location: Fort Lauderdale, FL
Date: February 7-10, 2013

Meeting Overview

Venue:
Broward County Convention Center
Primary Audience:
Primary Care
Credits:
Refer to the Accreditation Tab

As a primary care clinician, you are at the center of patient care.

Online registration for this event is now closed so that we may prepare for the program. Onsite registration opens Thursday, February 7, 2013 at 7:00 AM.

Whether diagnosing and treating an acute illness or managing patients with complex medical needs, you ensure optimal patient outcomes. Managing multiple priorities—from daily patient care to office administration—makes it difficult to leave the office and recharge.

Pri-Med Conference & Exhibition offers low-cost continuing medical education in a flexible format. The CME conference schedule is designed to maximize your time out of the office, providing clinical updates on the disease states and patients you treat daily.

  • Women’s health
  • Pediatric and adolescent medicine
  • Cardiology for primary care clinicians
  • And many more topics for CME or CE credit

Earn up to 27.25 AMA PRA Category 1 Credits™.

For 2013, Harvard Medical School and the University of Miami Miller School of Medicine have developed a curriculum of relevant lectures so you’re primed to deliver the best patient care.

Register for Pri-Med South by: Your price*
October 12 $30
November 30 $40
January 11 $55
February 2 $75
On-site at Pri-Med South $100

Have any ideas on how Pri-Med can improve your continuing medical education experience? Email us; we’d love to hear what you think.

*Price represents online registration. Registration by phone is an additional $10.

Primary Care Updates tracks are sponsored by pmiCME. This is a limited-capacity ticketed event available on a first-come, first-served basis and by registration.

Primary Care Updates activities are produced independently of and are not affiliated with Harvard Medical School and the University of Miami Miller School of Medicine.

 

Primary Care Updates*

February 7, 2013
A multi-track day of CME programs to supplement your education.

 

Current Clinical Issues in Primary Care

February 8–10, 2013
The core continuing medical education curriculum covering the latest topics in primary care medicine.

Harvard Medical School
University of Miami Miller School of Medicine
 

Educational Symposia

Independent, non-Harvard Medical School accredited CME sessions to expand your learning.


Non-CME Opportunities at Pri-Med South
Be the first to know the latest innovations, technologies, and product research in the health care industry.

Exhibit Hall
Face-to-face conversations with industry professionals, helpful takeaways, and engaging floor activities.
Learn More »

Presentation Theaters
Live discussions led by prominent medical thought leaders. Get an in-depth look at the latest tools and treatment options.
Learn More »


Sessions & Syllabus

Following is a recap of the core educational elements from the conference sessions, to help you take what you learned and apply it to your interactions with patients.

 

For your convenience, printer-friendly copies of the session slides are available to view and download approximately 1 week prior to the event. Materials will not be provided on-site. Review session slides prior to attending the program and come equipped with questions for our faculty.

Primary Care Updates, Thursday, February 07, 2013 | Jump to:  Track 1  Track 2 
  Primary Care Updates Track 1
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: Amarin Corporation plc, Boehringer Ingelheim Pharmaceuticals, Inc., Forest Research Institute, a subsidiary of Forest Laboratories, Inc., and Ironwood Pharmaceuticals, Novo Nordisk Inc. and Vivus.
7:00 AM-7:50 AM
Registration & Breakfast
7:50 AM-8:00 AM
Opening Remarks
8:00 AM-9:30 AM
Case Work: Evaluating GLP-1 Receptor Agonists in Patient-Centered Care for Type 2 Diabetes

Learning Objectives:

  1. Evaluate and apply current evidence regarding GLP-1 RA efficacy relative to other agents and across diabetes progression
  2. Evaluate and apply current evidence regarding safety of GLP-1 RAs, including recent data on specific label precautions (eg, thyroid cancer, pancreatitis, renal failure) and cardiovascular disease
  3. Evaluate and apply current evidence regarding tolerability and treatment satisfaction with GLP-1 RAs
  4. Evaluate and apply current evidence regarding nonglycemic effects of GLP-1 RAs (eg, effects on weight, blood pressure, lipid levels)
Derek LeRoith, MD, PhD, Mt Sinai School of Medicine, New York, NY
Javier Morales, MD (Read Bio), St. Francis Hospital, Vice President, Principal Clinical Trials Investigator, Advanced Internal Medicine Group, PC, Great Neck, NY
Jay Shubrook, DO, FACOFP, FAAFP, Associate Professor of Family Medicine, Director of Clinical Research, Department of Family Medicine, Director of Diabetes Fellowship, The Diabetes Institute, Ohio University Heritage College of Osteopathic Medicine, Athens, OH
9:30 AM-9:45 AM
AM Break
9:45 AM-11:15 AM
A New Frontier in Anticoagulation: Practical Issues and Considerations for Atrial Fibrillation Stroke Prevention in Primary Care

Learning Objectives:

  1. Apply the CHADS2 and HAS-BLED risk stratification tools in clinical practice to determine stroke and bleeding risk in patients with AF
  2. Incorporate current ACCP guideline recommendations and evidence-based approaches for stroke prevention in patients with AF while taking into account the benefit risk ratio of novel anticoagulants for each patient
  3. Recognize the importance of drug interactions, renal dysfunction, storage and handling in the application of novel anticoagulants in clinical practice
  4. Devise strategies to improve patient adherence and optimize outcomes in AF patients on novel anticoagulants undergoing surgery or experiencing bleeding
  5. Implement strategies for safe transitioning of AF patients to and from novel anticoagulants to improve patient outcomes
Bruce S. Stambler, MD, Professor of Medicine, Case Western Reserve University, Cleveland, OH
Kelley R. Branch, MD, MS, Assistant Professor, Attending Physician, University of Washington Medical Center, Seattle, WA
11:15 AM-12:30 PM
Tackling the Toughest Issues and Cases of Hypertriglyceridemia

Learning Objectives:

  1. Discuss the role of elevated triglyceride levels in the assessment and diagnosis of dyslipidemia, including cardiovascular risk factors
  2. Apply best practices in the attainment of TG levels, including the role of fasting and nonfasting states in accurate evaluation
  3. Evaluate the management of hypertriglyceridemia through greater adherence to evidenced based practices and accepted guidelines
  4. Select potential new and emerging therapeutic approaches to manage TG-based dyslipidemia, mixed dyslipidemia, and associated cardiovascular risk
William C. Cromwell, MD, FAHA, FNLA, Chief, Lipoprotein and Metabolic Disorders Institute, Raleigh, NC, Adjunct Associate Professor, Hypertension and Vascular Disease Center, Wake Forest University School of Medicine, Winston Salem, NC
Michael Miller, FACC, MD, FAHA, Professor, Departments of Medicine, Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, MD, Director, Center for Preventive Cardiology, University of Maryland Medical Center, Baltimore, MD
12:30 PM-1:15 PM
Lunch
1:15 PM-2:30 PM
Under Pressure: The Need to Expedite IBS Diagnosis and Treatment in Primary Care

Learning Objectives:

  1. Diagnose IBS based upon symptoms that may be shared with other functional gastrointestinal disorders or organic diseases
  2. Compare and contrast the efficacy and safety of available pharmacologic and non-pharmacologic treatment options for IBS
  3. Apply appropriate and comprehensive treatment strategies to enhance the care of patients with IBS
Brian E. Lacy, MD, PhD (Read Bio), Professor of Medicine, Dartmouth Medical School, Lebanon, NH
2:30 PM-2:45 PM
PM Break
2:45 PM-4:00 PM
Looking Past the Scale: Strategies to Promote Weight Loss and Reduce Co-Morbidities in Your Obese Patients

Learning Objectives:

  1. Evaluate the effect of obesity on the whole patient, focusing on identification of patients with increased BMI and the associated co-morbidities
  2. Identify strategies to engage both male and female patients in open dialogues about the benefits of weight reduction, highlighting the essential components of weight management and the importance of setting realistic weight loss goals
  3. Compare the safety and efficacy of currently available and novel agents in development for the treatment of obesity
Timothy Church, MD, MPH, PhD (Read Bio), Professor and Director, Laboratory of Preventive Medicine, Pennington Biomedical Research Center, Baton Rouge, LA
Donna H. Ryan, MD (Read Bio), Professor Emeritus Pennington, Pennington Biomedical Research Center, Baton Rouge, LA
4:00 PM-5:15 PM
Responsible Opioid Prescribing

Learning Objectives:

  1. Before initiating opioid therapy, obtain a comprehensive patient history to determine whether the patient may be at increased risk for opioid abuse
  2. Assess the most frequently encountered clinical and behavioral adverse effects of opioid therapy to incorporate into ongoing monitoring protocols in order to ensure patients are adhering to individualized treatment plans
Petros Levounis, MD, MA (Read Bio), Director, The Addiction Institute of New York, New York, NY, Chief, Division of Addiction Psychiatry, Associate Chair for Clinical Services, Department of Psychiatry & Behavioral Health, St. Luke's & Roosevelt Hospitals, New York, NY, Associate Clinical Professor of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY
The Responsible Opioid Prescribing session meets 1.25 AMA PRA Category 1 credits towards the Florida state mandated requirement for controlled substances CME education
  Primary Care Updates Track 2
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: AMGEN, Boehringer Ingelheim Pharmaceuticals, Inc., which was made possible, in part, through collaborations with Eli Lilly and Company, Lilly USA, LLC, Merck, sanofi-aventis U.S. Inc. and Vivus.
7:00 AM-7:50 AM
Registration & Breakfast
7:50 AM-8:00 AM
Opening Remarks
8:00 AM-9:30 AM
A Change in Diabetes Treatment Paradigms: Improving Glucose Control Without Hypoglycemia and Without Weight Gain

Learning Objectives:

  1. Assess current treatment goals for the comprehensive care of patients with type 2 diabetes
  2. Evaluate GLP-1 receptor agonists and DPP-4 inhibitors attributes relative to hypoglycemia and weight gain compared with other antiglycemic therapies
  3. Distinguish among available DPP-4 inhibitors
  4. Describe the role of the kidney in glucose homeostasis
Frank Lavernia, MD (Read Bio), Medical Founder and Director, North Broward Diabetes Center, Pompano Beach, FL
Richard Edwin Pratley, MD (Read Bio), Director, Diabetes Group, Sanford-Burnham Medical Research Institute, Orlando, FL, Director, Florida Hospital Diabetes Institute, Senior Scientist, Florida Hospital Sanford|Burnham Translational Research Instit, Professor, Sanford-Burnham Medical Research Institute, Orlando, FL, Chair in Diabetes Research, Director, Florida Hospital Diabetes Institute, Samuel E. Crockett, FL
9:30 AM-9:45 AM
AM Break
9:45 AM-11:00 AM
Looking Past the Scale: Strategies to Promote Weight Loss and Reduce Co-Morbidities in Your Obese Patients

Learning Objectives:

  1. Evaluate the effect of obesity on the whole patient, focusing on identification of patients with increased BMI and the associated co-morbidities
  2. Identify strategies to engage both male and female patients in open dialogues about the benefits of weight reduction, highlighting the essential components of weight management and the importance of setting realistic weight loss goals
  3. Compare the safety and efficacy of currently available and novel agents in development for the treatment of obesity
Timothy Church, MD, MPH, PhD (Read Bio), Professor and Director, Laboratory of Preventive Medicine, Pennington Biomedical Research Center, Baton Rouge, LA
Donna H. Ryan, MD (Read Bio), Professor Emeritus Pennington, Pennington Biomedical Research Center, Baton Rouge, LA
11:00 AM-12:15 PM
HPV Immunization: A Model for Cancer Prevention

Learning Objectives:

  1. Explain the epidemiology and burden of disease associated with HPV viruses
  2. Identify those HPV types most often associated with particular cancers and genital warts
  3. Discuss strategies to reduce the prevalence of these diseases
Kenneth A. Alexander, MD, PhD, Professor of Pediatrics, Chief, Section of Pediatric Infectious Diseases, University of Chicago Medical Center, Chicago, IL
Rachel Caskey, MD, MPP, Program Director, Med-Peds, Associate Section Chief, General Internal Medicine, Associate Section Chief, General Pediatrics, University of Illinois at Chicago, Chicago, IL
12:15 PM-1:00 PM
Lunch
1:00 PM-2:30 PM
Improving the Care of Patients with Chronic Pain: Individualized Assessment and Mechanism-Based Multimodal Treatment

Learning Objectives:

  1. Discuss the neurobiologic mechanisms that contribute to chronic pain and associated functional disability
  2. Assess biologic, psychological, and social factors utilizing treatment algorithms that contribute to chronic pain via detailed patient histories, comprehensive clinical interviews, and targeted physical exams
  3. Prescribe and tailor pharmacologic regimens for specific chronic pain pathways that reflect published evidence of efficacy, likely disease mechanisms, functional goals, and patient-specific risks of adverse outcomes
  4. Incorporate nonpharmacologic approaches and patient education to improve analgesia, functional gains, and treatment adherence
  5. Manage chronic pain in diverse patient populations, including older patients and patients with comorbid medical or psychiatric disorders
Bill McCarberg, MD (Read Bio), Founder, Chronic Pain Management Program, Kaiser Permanente, San Diego, CA, Assistant Clinical Professor, University of California, San Diego, San Diego, CA
Steven Stanos, DO (Read Bio), Assistant Professor, Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, IL, Medical Director, Rehabilitation Institute of Chicago, Chicago, IL, Chronic Pain Care Center, Chicago, IL
2:30 PM-2:45 PM
PM Break
2:45 PM-4:00 PM
Tipping the Balance: Strategies for Enhanced Detection and Treatment of Osteoporosis in Primary Care

Learning Objectives:

  1. Evaluate the risk of developing a fracture using currently available risk assessment tools
  2. Initiate the treatment of osteoporosis from risk assessment scores and bone mineral density (BMD) measurements
  3. Assess treatment decisions over time based upon the benefit:risk ratio of long-term therapy for individual patients
Michael Maricic, MD, Clinical Associate Professor of Medicine, University of Arizona College of Medicine, Tucson, AZ
E. Michael Lewiecki, MD, Clinical Assistant Professor of Medicine, University of New Mexico School of Medicine, Albuquerque, NM, Director, New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM
4:00 PM-5:30 PM
Complementary Therapies to Improve Glucose Control in Type 2 Diabetes: Role of GLP-1 Receptor Agonists & Basal Insulin

Learning Objectives:

  1. Apply strategies to individualized therapy in the treatment of patients with type 2 diabetes
  2. Incorporate appropriate strategies for timely initiation, selection, titration, and self-management of basal insulin in patients with type 2 diabetes
  3. Describe the similarities and differences between individual GLP-1 receptor agonists
  4. Summarize the clinical rationale and evidence for combining GLP-1 receptor agonists with basal insulin so as to address various underlying pathophysiologic components of type 2 diabetes
James R. Gavin, MD, PhD, III (Read Bio), CEO & Chief Medical Officer, Healing Our Village, Inc, Atlanta, GA, Clinical Professor of Medicine, Emory University School of Medicine, Atlanta, GA
Catherine Edwards, MD, FACE, Associate Professor, University of Florida Endocrine and Diabetes Division, Gainesville, FL
Friday, February 08, 2013
6:15 AM-7:45 AM Breakfast Symposia
6:15 AM-7:45 AM
Paul P. Doghramji FAAFP, MD (Read Bio), Attending Physician, Collegeville Family Practice, Collegeville, PA, Medical Director of Health Services, Ursinus College, Collegeville, PA, Cofounder, Brookside Family Practice and Pediatrics, Assistant Medical Director, Health Services, Hill School, Pottstown, PA
David W Baker MD, MPH, Michael A. Gertz Professor in Medicine, Chief, Division of General Internal Medicine and Geriatrics, Deputy Director, Institute for Public Health and Medicine, Feinberg School of Medicine, Chicago, IL
Commercial Support: The CME activity is supported by an educational grant from Lilly USA, LLC
7:45 AM-8:45 AM Keynote Address
7:45 AM-8:45 AM
Mark D. Aronson, MACP, MD (Read Bio)
Sanjiv Chopra, MD, MACP (Read Bio)
9:30 AM-11:30 AM Current Clinical Issues in Primary Care
Session 1: Ethics and Medicine

9:30 AM-10:30 AM Ethical Dilemmas in Primary Care Panel
Ken Goodman, PhD
Jeffrey Brosco, MD, PhD (Read Bio)
Raul DeVelasco, MD
10:30 AM-11:30 AM Doctors' Disability Assessments Make All the Difference
JoNel Newman, Esq (Read Bio)
Melissa Swain, Esq (Read Bio)
Session 2: Updates in Medicine

9:30 AM-10:10 AM Palliative Care - What the Primary Care Provider Needs to Know
Juan Palacio, MD
10:10 AM-10:50 AM Internet-Based Technologies for Health Promotion and Disease Prevention
Jorge Ruiz, MD
10:50 AM-11:30 AM Depression in Primary Care
Fernando Pomeraniec, MD
Session 3: Updates in Infectious Disease (ARS)

9:30 AM-10:10 AM Chronic Hepatitis C: A Multifaceted Disease
Sanjiv Chopra, MD, MACP (Read Bio)
10:10 AM-10:50 AM Overview of Infections due to Staph. Aureus
Gio Baracco, MD (Read Bio)
10:50 AM-11:30 AM Pneumonia - Making the Right Choices
Gordon Dickinson, MD (Read Bio)
11:45 AM-1:15 PM Lunch Symposia
11:45 AM-1:15 PM
Paul P. Doghramji FAAFP, MD (Read Bio), Attending Physician, Collegeville Family Practice, Collegeville, PA, Medical Director of Health Services, Ursinus College, Collegeville, PA, Cofounder, Brookside Family Practice and Pediatrics, Assistant Medical Director, Health Services, Hill School, Pottstown, PA
David W Baker MD, MPH, Michael A. Gertz Professor in Medicine, Chief, Division of General Internal Medicine and Geriatrics, Deputy Director, Institute for Public Health and Medicine, Feinberg School of Medicine, Chicago, IL
Commercial Support: The CME activity is supported by an educational grant from Lilly USA, LLC
1:30 PM-3:30 PM Current Clinical Issues in Primary Care
Session 4A: Ask The Expert: Neurology & GI (ARS)

1:30 PM-3:30 PM Panel discussion with Questions from the Audience
Galen Henderson, MD (Read Bio)
Ciaran Kelly, MD (Read Bio)
Session 5A: Women’s Health

1:30 PM-2:10 PM Top Advances in Women’s Health: Putting Research into Practice
Karen Carlson, MD (Read Bio)
2:10 PM-2:50 PM Osteoporosis - What's New
Silvina Levis-Dusseau, MD
2:50 PM-3:30 PM Insomnia: Special Issues for Women
Karen Carlson, MD (Read Bio)
Session 6A: The Patient Comes First

1:30 PM-2:30 PM *Domestic Violence: Secrets & Solutions 2013
Jane Sillman, MD (Read Bio)
2:30 PM-3:30 PM Old Drugs, New Thoughts/Uses
Jane Sillman, MD (Read Bio)
4:00 PM-6:00 PM Current Clinical Issues in Primary Care
Session 4B: Neurology & GI (ARS)

4:00 PM-4:40 PM Understanding Reflux - Diagnosis and Treatment
Daniel Sussman, MD
4:40 PM-5:20 PM Challenging Cases: Chronic Diarrhea
Ciaran Kelly, MD (Read Bio)
5:20 PM-6:00 PM Recent Advances in Stroke
Galen Henderson, MD (Read Bio)
Session 5B: Hospital Care

4:00 PM-4:40 PM Perioperative Management of Anticoagulation
Amir Jaffer, MD
4:40 PM-5:20 PM Acute Renal Failure - First Responses
Warren Kupin, MD
5:20 PM-6:00 PM Best Practices for Hand-Overs at the Transitions of Care
Jocelyn David, MD
Session 6B: Pulmonary Diseases

4:00 PM-4:40 PM Approach and Management of Pulmonary Hypertension
Jaime Avecillas, MD
4:40 PM-5:20 PM COPD Update
Michael Campos, MD (Read Bio)
5:20 PM-6:00 PM Approach to Sleep Disorders
David Zuckerman, MD
6:15 PM-8:45 PM Dinner Symposia
6:15 PM-8:45 PM
Bill McCarberg MD (Read Bio), Founder, Chronic Pain Program, Kaiser Permanente, San Diego, CA
Michael J. Brennan MD, FACP, FASAM (Read Bio), Private Practice, Physical Medicine and Rehabilitation, Senior Attending Physician, Department of Medicine, Section Pain Management & Rehabilitation, Bridgeport Hospital, Bridgeport, CT
Marc R Gerber MD, PA, Private Practice, MRG Rehabilitation & Pain Medicine, Orlando, FL
Roy Furman, Medical Director, Chief Information Offi cer, Intelligent Medical Decisions, Inc., Media, PA
Accreditation: This activity has been accredited by Global Education Group. (Read Accreditation/Designation Statement)
Commercial Support: The CME activity is supported by an educational grant from Mallinckrodt, the Pharmaceuticals business of Covidien
6:15 PM-7:45 PM Dinner Symposia
6:15 PM-7:45 PM
Paul P. Doghramji FAAFP, MD (Read Bio), Attending Physician, Collegeville Family Practice, Collegeville, PA, Medical Director of Health Services, Ursinus College, Collegeville, PA, Cofounder, Brookside Family Practice and Pediatrics, Assistant Medical Director, Health Services, Hill School, Pottstown, PA
David W Baker MD, MPH, Michael A. Gertz Professor in Medicine, Chief, Division of General Internal Medicine and Geriatrics, Deputy Director, Institute for Public Health and Medicine, Feinberg School of Medicine, Chicago, IL
Commercial Support: The CME activity is supported by an educational grant from Lilly USA, LLC
Saturday, February 09, 2013
6:15 AM-7:45 AM Breakfast Symposia
6:15 AM-7:45 AM
Mark W. Stolar MD, Associate Professor of Clinical Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Frank Lavernia MD (Read Bio), Founder and Director, North Broward Diabetes Center, Pompano Beach, FL
Commercial Support: The CME activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., which was made possible in part, through a collaboration with Eli Lilly and Company
7:45 AM-8:45 AM Keynote Address
7:45 AM-8:45 AM
Holly G Atkinson, MD (Read Bio), Assistant Clinical Professor of Medicine, Director, Human Rights Program and Co-Director, Advancing Idealism in Medicine Program, Mount Sinai School of Medicine, New York, NY, Adjunct Professor of Public Health, Weill Medical College of Cornell University, New York, NY
9:30 AM-11:30 AM Current Clinical Issues in Primary Care
Session 7: Drugs - What’s Old, What’s New

9:30 AM-10:10 AM Vitamin D Controversy: What Works and What Doesn't
Frank Domino, MD (Read Bio)
10:10 AM-10:50 AM New Drugs for the Primary Care Provider: What You Need to Know
Gerald Smetana, MD (Read Bio)
10:50 AM-11:30 AM What's New in Lipid Management
Ronald Goldberg, MD (Read Bio)
Session 8: Medicine Potpourri (ARS)

9:30 AM-10:10 AM Smoking Cessation - New Tricks for an Old Problem
David Andrade, MD
10:10 AM-10:50 AM Abuse and Neglect of the Elderly
Pat Caralis, MD, JD, FACP (Read Bio)
10:50 AM-11:30 AM Rapid Consultation: 5 Most Common Infectious Disease Outpatient Concerns
Demetre Daskalakis, MD (Read Bio)
11:45 AM-1:15 PM Lunch Symposia
11:45 AM-1:15 PM
Mark W. Stolar MD, Associate Professor of Clinical Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Frank Lavernia MD (Read Bio), Founder and Director, North Broward Diabetes Center, Pompano Beach, FL
Commercial Support: The CME activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., which was made possible in part, through a collaboration with Eli Lilly and Company
11:45 AM-1:15 PM
James R. Gavin MD, PhD, III (Read Bio), Clinical Professor of Medicine, Emory University School of Medicine, Atlanta, GA, CEO & Chief Medical Officer, Healing Our Village, Inc, Atlanta, GA
Scott V. Joy FACP, MD (Read Bio), Medical Director, The Colorado Health Foundation, Denver, CO, High Street Primary Care, Presbyterian/St Luke's Medical Center, Denver, CO, Associate Professor of Medicine, The University of Colorado Health System, Denver, CO
Davida F Kruger MSN, BC-ADM, APRN, Certified Nurse Practitioner, Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System, Detroit, MI, Division of Endocrinology, Diabetes and Bone Mineral Disorders, Detroit, MI
Commercial Support: The CME activity is supported by an educational grant from Novo Nordisk Inc.
1:30 PM-3:30 PM Current Clinical Issues in Primary Care
Session 9A: Literature Updates (ARS)

1:30 PM-2:10 PM What You Need to Know from the Medical Literature: Part I
Frank Domino, MD (Read Bio)
2:10 PM-2:50 PM What You Need to Know from the Medical Literature: Part II
Mark Aronson, MACP, MD (Read Bio)
2:50 PM-3:30 PM Screening for Prostate Cancer: An Evidence-Based Approach
Ben Hassan, MD
Session 10A: Specialist Care

1:30 PM-2:10 PM Abdominal Pain - Surgeon's Perspective
Seth Spector, MD
2:10 PM-2:50 PM Common ENT Problems
Kenneth Nissim, MD
2:50 PM-3:30 PM Chronic Pain Management of Non Cancer Patients
Konstantinos Sarantopoulos, MD
Session 11A: Common & Vexing Problems

1:30 PM-2:10 PM Rheumatology Pearls for Primary Care
Larry Young, MD
2:10 PM-2:50 PM When to Consider Total Hip and Knee Replacement
Michaela Schneiderbauer, MD
2:50 PM-3:30 PM Foot and Ankle Problems
Mike Cohen, DPM
4:00 PM-6:00 PM Current Clinical Issues in Primary Care
Session 9B: Medical Jeopardy (ARS)

4:00 PM-6:00 PM Medical Jeopardy
Mark Aronson, MACP, MD (Read Bio)
Session 10B: Pediatric & Adolescent Medicine

4:00 PM-4:40 PM The New Community Acquired Pneumonia Guidelines
Kenan Haver, MD (Read Bio)
4:40 PM-5:20 PM A Primary Care Provider's Guide to Autism
Jeffrey Brosco, MD, PhD (Read Bio)
5:20 PM-6:00 PM Pediatric Updates from Medical Literature
Harvey Katz, MD (Read Bio)
Session 11B: Diabetes

4:00 PM-4:40 PM It's Not Sugar: Type 2 Diabetes Evidence and Controversy
Frank Domino, MD (Read Bio)
4:40 PM-5:20 PM Obesity - New Modalities and Motivations
Hermes Florez, MD (Read Bio)
5:20 PM-6:00 PM Diabetes - What's the Bottom Line?
Jennifer Marks, MD
6:15 PM-7:45 PM Dinner Symposia
6:15 PM-7:45 PM
Mark W. Stolar MD, Associate Professor of Clinical Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Frank Lavernia MD (Read Bio), Founder and Director, North Broward Diabetes Center, Pompano Beach, FL
Commercial Support: The CME activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., which was made possible in part, through a collaboration with Eli Lilly and Company
Sunday, February 10, 2013
7:45 AM-8:45 AM Keynote Address
7:45 AM-8:45 AM
Steven G Ullman, PhD (Read Bio)
9:30 AM-11:30 AM Current Clinical Issues in Primary Care
Session 12: Ask the Expert: Cardiovascular & Pulmonary Medicine

9:30 AM-11:30 AM Panel Discussion with questions from the audience
Christopher Fanta, MD (Read Bio)
Joshua Beckman, MD, MS (Read Bio)
Session 13: Pediatric & Adolescent Medicine (ARS)

9:30 AM-10:10 AM Challenging Cases: What’s Your Diagnosis
Harvey Katz, MD (Read Bio)
10:10 AM-10:50 AM Allergy and Urticaria in Adolescents
Lauren Fine, MD
10:50 AM-11:30 AM Asthma Updates You Need to Know
Kenan Haver, MD (Read Bio)
1:30 PM-3:30 PM Current Clinical Issues in Primary Care
Session 14: Cardiopulmonary Medicine

1:30 PM-2:10 PM 'Coughing My Brains Out' -- Approach to the Patient with Chronic Cough
Christopher Fanta, MD (Read Bio)
2:10 PM-2:50 PM Advances in Treatment of Ischemic Heart Disease
Carlos Alfonso, MD
2:50 PM-3:30 PM Management of the Asymptomatic Carotid Artery
Joshua Beckman, MD, MS (Read Bio)
Session 15: Chronic Illness (ARS)

1:30 PM-2:10 PM Hypertension Update
Gerald Smetana, MD (Read Bio)
2:10 PM-2:50 PM Management of Chronic Dialysis and Chronic Renal Failure Patients
Ivonne Schulman, MD
2:50 PM-3:30 PM Treatment of Migraine
Gerald Smetana, MD (Read Bio)

Additional Opportunities

 
Product Theater
11
AM
12
PM
11:35 AM-12:20 PM
Acne Matters: Tips to Treat and Manage Acne
Brought to you by: Galderma Laboratories LP

11:35 AM-12:20 PM
A Low-Volume Formulation for the Treatment of Hypogonadism
Brought to you by: AbbVie

11:35 AM-12:20 PM
The Role of Combination Therapy in Mixed Dyslipidemia
Brought to you by: AbbVie

11:35 AM-12:20 PM
Revisiting Hypoglycemia
Brought to you by: Novo Nordisk Inc.

11:35 AM-12:20 PM
Allergic Rhinitis: Addressing the Unmet Needs
Brought to you by: Teva Respiratory

12
PM
1
PM
12:40 PM-1:25 PM
The Clinical Use of Pradaxa® (dabigatran etexilate mesylate) capsules
Brought to you by: Boehringer Ingelheim Pharmaceuticals, Inc.

12:40 PM-1:25 PM
Individualizing Care for Patients with Overactive Bladder
Brought to you by: Pfizer Inc.

12:40 PM-1:25 PM
Type 2 Diabetes and GLP-1 Therapy: Learn the Link
Brought to you by: Novo Nordisk Inc.

 
Product Theater
9
AM
9:00 AM-9:30 AM
Dupuytren's Contracture
Brought to you by: Auxilium Pharmaceuticals, Inc.

11
AM
12
PM
11:35 AM-12:20 PM
Helicobacter pylori: Importance of Appropriate Testing and Management
Brought to you by: OAPI - Medical Device Division

11:35 AM-12:20 PM
LIVALO: A Clinical Update
Brought to you by: Kowa Pharmaceuticals and Lilly USA

11:35 AM-12:20 PM
The Clinical Profile of Daliresp (roflumilast)
Brought to you by: Forest Pharmaceuticals, Inc.

11:35 AM-12:20 PM
Improving Glycemic Control Through DPP-4 Inhibition: Treatment Considerations for Adult Patients with Type 2 Diabetes
Brought to you by: Boehringer Ingelheim & Eli Lilly

12
PM
1
PM
12:40 PM-1:25 PM
Case Studies: Practical Management of Gout
Brought to you by: Takeda Pharmaceuticals U.S.A., Inc.

12:40 PM-1:25 PM
Therapeutic Considerations for Successful Asthma Management
Brought to you by: Teva Respiratory

12:40 PM-1:25 PM
VASCEPA® A New Therapy for the Treatment of Severe Hypertriglyceridemia
Brought to you by: Amarin Pharma, Inc.

 
Product Theater
9
AM
9:00 AM-9:30 AM
Clinical Insights to COPD: A Lecture for Health Care Professionals
Brought to you by: Forest Pharmaceuticals, Inc.

9:00 AM-9:30 AM
Type 2 Diabetes Mellitus (T2DM): Pathophysiology, Therapeutic Needs, and Modulation of Glucose Homeostasis
Brought to you by: Janssen Pharmaceuticals, Inc.

9:00 AM-9:30 AM
Alternative Fuel for Brain Cells: Improving Memory & Cognition in Alzheimers disease* Patients with a Prescription Medical Food
Brought to you by: Accera, Inc.

11
AM
12
PM
11:35 AM-12:20 PM
Pneumococcal Disease in Adults 50+: A Prevention Option for Your Patients
Brought to you by: Pfizer Inc.

11:35 AM-12:20 PM
Niaspan AIM-HIGH Final Results and Implications
Brought to you by: Abbvie

11:35 AM-12:20 PM
Reevaluating Overall Glycemic Control
Brought to you by: Novo Nordisk Inc.

Accreditation

Harvard Medical School 50x61

Current Clinical Issues in Primary Care

The educational program, Current Clinical Issues in Primary Care, is developed by the Course Development Committee of Harvard Medical School and the University of Miami Miller School of Medicine. All decisions about the program content and faculty are made exclusively by the Course Development Committee. It is the mission of the Course Development Committee to develop, present, and promote an educational opportunity that is timely, relevant, free of commercial influence, and of the highest quality. To that end, we welcome your comments about how better so serve your needs.

Credits Type Accreditation Statement Designation Statement
19 AMA PRA Category 1 Credits™ The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Harvard Medical School designates this live educational activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
19 AAFP This activity has been reviewed and is acceptable for up to 19 Prescribed credits by the American Academy of Family Physicians.

Primary Care Updates

This educational program is conceived and created in accordance with Accreditation Council for Continuing Medical Education (ACCME) Accreditation Criteria, the ACCME Standards for Commercial Support℠, and ACCME Policies. Pri-Med faculty hail from a variety of institutions and participate in content development, along with pmiCME’s Advisory Boards and its expert review partner, Tufts Health Care Institute. All final decisions about program content are the responsibility of pmiCME.

Track 1

Credits Type Accreditation Statement Designation Statement
8 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
8 AAFP This live activity, Pri-Med South 2013, with a begin date of 2/7/2013-2/10/2013, has been reviewed and is acceptable for up to 8 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
8 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 8 contact hours of continuing education (which includes 4.000 hours of pharmacology).

Primary Care Updates

Track 2

Credits Type Accreditation Statement Designation Statement
8.25 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
8.25 AAFP This live activity, Pri-Med South 2013, with a begin date of 2/7/2013-2/10/2013, has been reviewed and is acceptable for up to 8.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
8.25 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 8.25 contact hours of continuing education (which includes 4.125 hours of pharmacology).

Keynote Speakers

Mark Aronson, MACP, MD (Read Bio)

Presenting on:

Sanjiv Chopra, MD, MACP (Read Bio)

Director, Harvard Medical School Course Development Committee

Presenting on:

Holly Atkinson, MD (Read Bio)

Director, Human Rights Program and Co-Director, Advancing Idealism in Medicine Program
Mount Sinai School of Medicine, New York, NY
Weill Medical College of Cornell University, New York, NY

Presenting on:

  • Should Medical Professionalism Include Advocacy?
    Saturday (February 09, 2013), 7:45 AM-8:45 AM

Steven Ullman, PhD (Read Bio)

Presenting on:

Exhibit Hall

Pri-Med Exhibit Hall

Hours
Friday, February 8 8:30 AM–2:30 PM
Saturday, February 9 8:30 AM–2:30 PM
Sunday, February 10 8:30 AM–2:00 PM

The Pri-Med Exhibit Hall is your chance to learn about and compare over 175 of the health care industry’s latest products, treatments, and technologies in one place.

Visit the Amazing Charts booth #923 at Pri-Med South.

Learn about the #1 rated EHR for a chance to win an iPad Mini.

Presentation schedule:
8:45 AM Intro to EHR
11:30 AM Intro to EHR
NOON Meaningful Use
12:30 AM Intro to ERH
1:00 PM Latest Features


Spend your time in the Exhibit Hall talking to company representatives, evaluating new options, and making purchasing decisions for your practice—all things you do not have time for in your daily schedule. 

Attendee Badge Information

Please Note: As a Pri-Med registrant, you will receive a badge and an Attendance Scan Card, which will have bar codes programmed with your name, address, and professional discipline. You will scan your bar code at the appropriate stations to obtain CME credit or nursing contact hours.

Scanning your card at an exhibit booth or non-CME activity gives the sponsor permission to use your contact information for future correspondence.

 

Exhibit Floor Highlights

Presentation Theaters

Join us for an informative snack break, lunch, or dinner discussion about the latest clinical information as it relates to a specific disease state.

Lunchtime workshops in the Presentation Theaters will focus on ways to boost revenue by adding ancillary products and services to your practice. Come and learn from some of the leading experts in the industry.

Exhibitor List

Company Name Booth Number
1-800 Notify 1125
AbbVie 123
Aegis Sciences Corporation 1010
Alzheimers Association 814
Amazing Charts 923
American College of Physicians 104
American Express 1011
AspirinWorks by Corgenix 822
Auxilium Pharmaceuticals, Inc. 524
Bionix 209
Boehringer Ingelheim Pharmaceuticals, Inc. 201
Boston Heart Diagnostics 122
Cargill 719
Cell Science Systems/ ALCAT 918
Civilian Corps U.S. Army Medical Command 817
Clinix 110
COPD Foundation 325
CryoSurgery, Inc 218
Dermalogix Partners Inc 115
Doximity 527
Elsevier Medical Books 400
Forest Pharmaceuticals, Inc. 415
Galderma Laboratories LP 803
Global Life Technologies Corp 106
Health Diagnostic Laboratory 112
HOLOGIC, Inc. 116
Ideal Protein 217
Infinite Therapeutics 1110
JSA Medical Group 424
Laclede Inc 916
Lippincott Williams & Wilkins 705
Maico Diagnostics 422
Medical Device Division Otsuka America Pharmaceutical 100
MedTech Associates 823
Merck 825
Mission Pharmacal Co 804
Natus Medical 318
New Balance Athletic Shoes/Aravon Shoes 1111
Novo Nordisk Inc. 403
Novo Nordisk Inc. 605
Pfizer Inc. 315
Premier Medcl Products 914
Savient Pharmaceuticals 216
Schumacher Group 316
Summit Doppler Systems 723
Take Shape for Life 214
Tec Laboratories, Inc. 423
Teva Respiratory 727
Ultimate Creations 1116
Viora 525
VitalMD Group Holding, LLC 715
WebToMed 902
Company Name Booth Number
A Fashion Hayvin, Inc. 1019
Accera, Inc. 303
Allergy Free Labs 323
Amarin Pharma, Inc. 917
American Academy of Anti-Aging Medicine 726
American Diabetes Association 908
Army National Guard 1012
Atherotech 824
Biofilm, Inc. 119
Bio-Oil 810
Boiron 311
Calmoseptine 707
Carlson Laboratories 801
Challenger Corporation 900
Clarity Genetics, Inc. DBA Clarity Women's Health 402
Concentra 1127
CryoProbe 711
Daiichi Sankyo, Inc 612
DKBmed 301
Ellman International, LLC 819
Florida Center for Allergy & Asthma Care 324
FRONTRUNNERS BOARD REVIEW 322
GE Healthcare 101
HAE: Learn About It, Talk About It 913
Hemosure, Inc. 117
Horizon Pharma USA, Inc 725
i-Lipo / Chromogenex 904
Intimina by Lelo 815
Kowa Pharmaceuticals 622
Life Extension 523
LocumTenens.com 522
Mederi Therapeutics, Inc 809
MediTouch EHR / HealthFusion 305
Merck 1101
Micro Direct, Inc. 911
MPR 114
Neilmed Pharmaceuticals, Inc. 816
Novartis Pharmaceuticals 109
Novo Nordisk Inc. 409
Nutramax Laboratories, Inc. 811
PractRx 215
Pri-Med 1023
Scarf King 1123
Shader Productions 1117
Take Care Health Systems 308
Takeda Pharmaceuticals U.S.A., Inc. 901
Televox Software, Inc. 410
The Gideons International 1119
Verathon Medical 808
ViroPharma Incorporated 709
Vitamix 1017
WynnPharm 314
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Broward County Convention Center
1950 Eisenhower Blvd
Fort Lauderdale, FL 33316-4205
(954) 765-5900